Definium Therapeutics, Inc. Proceeds from Stock Options Exercised
Definium Therapeutics, Inc. (DFTX) reported Proceeds from Stock Options Exercised of $2.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2026-08-06
- Definium Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2026-06-30 was $860.00K, a 786.60% increase year-over-year.
- Definium Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2026-03-31 was $1.20M, a 404.64% increase year-over-year.
- Definium Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2025-12-31 was $193.00K, a 328.89% increase year-over-year.
- Definium Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2025-09-30 was $98.00K, a 206.25% increase year-over-year.
- Definium Therapeutics, Inc. proceeds from stock options exercised for fiscal 2025 was $625.00K, a 12.71% decline from fiscal 2024.
- Definium Therapeutics, Inc. proceeds from stock options exercised for fiscal 2024 was $716.00K, a 1361.22% increase from fiscal 2023.
- Definium Therapeutics, Inc. proceeds from stock options exercised for fiscal 2023 was $49.00K, a 76.21% decline from fiscal 2022.
- Definium Therapeutics, Inc. proceeds from stock options exercised for fiscal 2022 was $206.00K, a 96.40% decline from fiscal 2021.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $860.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.06M 10-Q · filed 2026-08-06 | $2.25M derived: sum of 3 quarters · filed 2026-08-06 | $2.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-07 | $1.39M derived: sum of 2 quarters · filed 2026-05-07 | $1.49M derived: sum of 3 quarters · filed 2026-05-07 | $1.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $291.00K derived: sum of 2 quarters · filed 2026-02-26 | $388.00K derived: sum of 3 quarters · filed 2026-08-06 | $625.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $195.00K derived: sum of 2 quarters · filed 2026-08-06 | $432.00K 10-Q · filed 2025-11-06 | $477.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $334.00K 10-Q · filed 2026-08-06 | $379.00K derived: sum of 3 quarters · filed 2026-08-06 | $411.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $237.00K 10-Q · filed 2026-05-07 | $282.00K derived: sum of 2 quarters · filed 2026-05-07 | $314.00K derived: sum of 3 quarters · filed 2026-05-07 | $488.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $77.00K derived: sum of 2 quarters · filed 2026-02-26 | $251.00K derived: sum of 3 quarters · filed 2026-02-26 | $716.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $206.00K derived: sum of 2 quarters · filed 2025-11-06 | $671.00K 10-Q · filed 2025-11-06 | $720.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $174.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $639.00K 10-Q · filed 2025-07-31 | $688.00K derived: sum of 3 quarters · filed 2025-07-31 | |
| 2024-03-31 | $465.00K 10-Q · filed 2025-05-08 | $514.00K derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $49.00K 10-K · filed 2025-03-06 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $83.00K derived: sum of 2 quarters · filed 2024-02-28 | $83.00K derived: sum of 3 quarters · filed 2024-02-28 | $206.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $83.00K derived: sum of 2 quarters · filed 2023-11-02 | $206.00K 10-Q · filed 2023-11-02 | $340.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $123.00K 10-Q · filed 2023-08-03 | $257.00K derived: sum of 3 quarters · filed 2023-08-03 | $572.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $123.00K 10-Q · filed 2023-05-04 | $257.00K derived: sum of 2 quarters · filed 2023-05-04 | $572.00K derived: sum of 3 quarters · filed 2023-05-04 | $4.67M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $449.00K derived: sum of 2 quarters · filed 2023-03-09 | $4.54M derived: sum of 3 quarters · filed 2023-03-09 | $5.72M 10-K · filed 2023-03-09 |
| 2021-09-30 | $315.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $4.41M derived: sum of 2 quarters · filed 2022-11-10 | $5.59M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $4.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $5.27M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $1.18M 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $648.00K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |